The Dermatology Treatment Devices market research report serves as a comprehensive resource providing current and forthcoming technical and financial details within the healthcare industry for a specific forecast period. This report highlights significant product developments and monitors recent acquisitions, mergers, and research activities in the healthcare industry by key players. Offering a precise examination of the Dermatology Treatment Devices industry, the market report elucidates market definitions, classifications, applications, engagements, and global industry trends. Businesses can leverage the leading Dermatology Treatment Devices market report for informed decision-making, revenue generation, prioritizing market goals, and achieving long-lasting success.
The top-notch Dermatology Treatment Devices report organizes global data breakdowns by manufacturers, region, type, and application, analyzing market status, share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, and distributors. Moreover, businesses can formulate strategies related to products, customers, key players, sales, promotion, or marketing through a detailed analysis of competitive markets. This market report classifies companies based on geographical region, type, component, application, and end-use industry, addressing the market with a tailored understanding of customer requirements.
Data Bridge Market Research analyses that the Dermatology Treatment Devices Market is expected to reach the value of USD 17,786.65 million by the year 2029, at a CAGR of 15.63% during the forecast period. Technological advancements in products and procedures, rising incidence of skin disorders, rising healthcare expenditure, and an ageing global population will all contribute to the market’s growth.
Skin disease is one of the leading causes of the growing global disease burden, affecting millions of people around the world. Aging, as well as environmental and genetic factors, contribute to the development of a wide range of skin diseases. Melanoma and non-melanoma skin cancers are becoming increasingly common. As a result, there has been a consistent rise in the number of skin problems over the last few years, which may aid in the overall market’s growth.
Drivers
The rise in the cases of dermatological diseases
The increase in the prevalence of diseases requiring surgical treatment, particularly minimally invasive surgery (MIS), is attributed to market growth, which will help the dermatology devices market gain traction in the coming years. Furthermore, the rising prevalence of skin disorders, which necessitate the use of dermatology devices to manage the condition, is expected to propel the market to higher revenue shares.
The increase in the healthcare spending
The rising prevalence of conditions such as psoriasis, acne, and other skin disorders is expected to boost market revenue during the forecast period. Increased healthcare spending, which can be used to treat skin conditions, would aid the market’s growth during the forecast period. Furthermore, the increased need for aesthetic improvement, which necessitates the use of dermatology devices, fuels market growth.
Some key players mentioned in the report are:
Agfa-Gevaert Group (Belgium), Carl Zeiss AG (Germany), MELA Sciences, Inc. (US), Hologic, Inc. (US), Illumina, Inc. (US), Spindletop Capital (US), Heine Optotechnik (Germany), GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), Leica Microsystems (Germany), Bruker (US), Solta Medical (US), CANDELA CORPORATION (US), Ambicare Health (UK), Siemens Healthcare Private Limited (Germany), Welch Allyn (US), CANON MEDICAL SYSTEMS CORPORATION (Japan), Galderma laboratories (US), Michelson Diagnostics Inc. (UK) and Canfield Scientific, Inc. (US)
Furthermore, this Dermatology Treatment Devices Market study will help our clients solve the following issues:
Cyclical dynamics – We foresee dynamics of industries by using core analytical and unconventional market research approaches. Our clients use insights provided by us to maneuver themselves through market uncertainties and disruptions
Identifying key cannibalizes – Strong substitute for a product or service is the most prominent threat. Our clients can identify key cannibalizes of a market, by procuring our research. This helps them in aligning their new product development/launch strategies in advance
Spotting emerging trends – Our Ecosystem offering helps the client to spot upcoming hot market trends. We also track possible impact and disruptions which a market would witness by a particular emerging trend. Our proactive analysis helps clients to have an early mover advantage
Interrelated opportunities – This Dermatology Treatment Devices Market report will allow clients to make decisions based on data, thereby increasing the chances that the strategies will perform better if not best in the real world
Comprehensive Overview: The report offers a 360-degree overview of the Dermatology Treatment Devices market, providing a global and regional perspective.
Market Share and Sales Revenue: It analyzes the market share and sales revenue of key players in the industry, as well as emerging regional players, to understand their market position.
Market Entropy: A dedicated chapter focuses on Market Entropy, offering insights into the aggressiveness of market leaders through activities such as mergers and acquisitions, recent investments, and key developments.
Patent Analysis: The report includes a patent analysis, examining the number of patents and trademarks filed in recent years, which indicates the level of innovation and intellectual property within the industry.
Guide for New Market Aspirants: The report serves as a complete and useful guide for new market entrants, providing them with valuable information to understand the industry landscape, opportunities, and challenges.
Forecast Information: The report provides forecast information that will assist in developing strategic and innovative business plans. It also includes a SWOT analysis of players, enabling the identification of growth opportunities, risk analysis, and investment feasibility.
The availability and feasibility of data may vary depending on the specific industry targeted in the study. Nonetheless, the report aims to deliver valuable insights and recommendations for businesses operating in the Dermatology Treatment Devices market.
The Dermatology Treatment Devices market report covers the following countries across different regions:
North America: The United States, Canada, and Mexico.
Europe: Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and the rest of Europe.
Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, the Philippines, and the rest of Asia-Pacific.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and the rest of Middle East and Africa.
South America: Brazil, Argentina, and the rest of South America.
North America province dominates the dermatology treatment devices industry due to rising prevalence of skin cancer and other skin diseases such as eczema and rosacea, as well as rising adoption of cosmetic dermatology procedures, whereas Asia-Pacific (APAC) is expected to grow at the fastest rate in the estimated period due to the availability of affordable treatment options, which leads to increased medical tourism and increased beauty consciousness.
Key Market Segmentation
Agfa-Gevaert Group (Belgium), Carl Zeiss AG (Germany), MELA Sciences, Inc. (US), Hologic, Inc. (US), Illumina, Inc. (US), Spindletop Capital (US), Heine Optotechnik (Germany), GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), Leica Microsystems (Germany), Bruker (US), Solta Medical (US), CANDELA CORPORATION (US), Ambicare Health (UK), Siemens Healthcare Private Limited (Germany), Welch Allyn (US), CANON MEDICAL SYSTEMS CORPORATION (Japan), Galderma laboratories (US), Michelson Diagnostics Inc. (UK) and Canfield Scientific, Inc. (US)
Recent Development
Lancer Skincare announced the release of its first skincare exfoliating device, the Pro Polish Microdermabrasion Device, in July 2020. By delivering surface-layer microdermabrasion in a patented, handheld device, Pro Polish improves the efficacy of the Lancer routine.
3Derm Systems, Inc. (3Derm) announced in January 2020 that it had received two FDA Breakthrough Device designations for 3DermSpot, an algorithm that uses artificial intelligence (AI) and highly standardised skin images to detect melanoma, squamous cell carcinoma, and basal cell carcinoma autonomously.
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.